EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS197-02567 
Organism
Homo sapiens 
Tissue/cell
ZR75-30 
Coordinate
chr10:30791040-30792070 
Target genes
Number: 1             
NameEnsembl ID
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
IRF1MA0050.2chr10:30791627-30791648TCTCAGTTTCTTTTTTATTTT+6.74
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_09662chr10:30790663-30792284CD14
SE_20388chr10:30788780-30795655CD56
SE_58781chr10:30776570-30801040Ly1
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr103079129930791558
Number: 1             
IDChromosomeStartEnd
GH10I030501chr103079053530795620
Enhancer Sequence
TGACTTTTTT TCCCCTAAAG TAAAAAGTTT ACTACCTTCC CATCATGTTT CTTAATGTTT 60
TATTAAGACA CTCTGTAGAG AAAAATAGCA ATTGATAAGA CTCTTTTAAC AAAGATGTTA 120
TTATTTTTAG ACTTTTTAAA GTAGGCATTC CAATTTGGCA TAACTTTACC CAGCTACTCT 180
TTCAAGAGGA CTTGTGTTTA TAATTTCGCA TTTTGCCTAA GTAGAAAAAC ATCTCATTTC 240
TTGTACTTAG GAAGTGGTTT CAGCAGCTGG AAAGACCTCA GGCTCAGAGT GTGATAAGCA 300
GTCGTCGCAG AACCGGGCTT CTGACCACAC AGCCTGAGGC TACCACGGAT AGGAGGCACC 360
ACCCAGAAAT GTCACATCTC AGTGGCTAAG GCTAAGCCAT TTGAGAATTT GCATCAATCC 420
ACCCAAATGA ATGATGAAAA GTGAAAGAAA TCACACTACC TCATCTTTAT GCATCAAACA 480
ATTTCTTATA AAGCCATTAG TTCTAACAGT TTTTCAGGTG GGGAAGGTAG GTCTCAAAAC 540
TCCCAGAAAT TTAGTGAATT TCTTGTTTGT TGTAGTAGGT TCGTTTTTCT CAGTTTCTTT 600
TTTATTTTTC TGATCCTGTA ACACTTTCTT TGCATCCCTT TGCTTCTTCA GCCTTTGTGA 660
CGGGCATGCA CTCTGGTGAC GCACCCTGGG GACACTGTCT TTTCCCTTTA GTAGTCCCTA 720
CTGCTGCAGC CCTATGCGGT CAAACTCCTT CCAGAGGCAT TTCCATTTGA ATATCTGAAT 780
TAAGGTGAAG GTACAGCCAC GTGGCTCTTC ACCCAGCTGC CTCACACACT CCACTGGTTC 840
TCTCCCACCT TGCTCAAGCT TCTTTCTCTT CTTTGCAGCT TTTTGCAAGG CTCAGCCAAC 900
ATATTTTCAC TCTTCATTCT ATTCCTAAGC CATCTCACCT ATTCCGGGGA TCTCCATCTA 960
CATGCTAATC ATGGCTATCA ATCTACATGT TACATGCTAC ATGTGACAAC CATGGCTATC 1020
AGTCTACATG 1030